The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Type 2 diabetes risk rises after COVID-19 People may b..
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Antibodies in kids after COVID last 6 months or more M..
Moderna Inc (MRNA.O) said on Wednesday it will ask regulators to authorize its COVID-19 vaccine in children younger than 6 years old based on data showing it generated a similar immune response to adults in its clinical trial. The Omicro..
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years. The authorization is a global first for the age group for the vaccine, which is manuf..
Pfizer will supply up to 4 million courses of its oral Covid-19 treatment to dozens of poorer nations under an agreement with the United Nations Children’s Fund, the company announced Tuesday. Pfizer expects to start supplying..
Bristol Myers Squibb Co (BMY.N) said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer. The company said it expects the ..
Getting infected twice with two different Omicron coronavirus subvariants is possible, but rarely happens, a Danish study has found. In Denmark, a more infectious sublineage of the Omicron coronavirus variant known as BA.2 has quickly dethroned th..
Introduction: It would help if you did not give up on the IVF procedure easily. There are millions of women who have received successful pregnancy through IVF process. It is not necessary that you get the results in the first IVF cycle. The medica..
The World Health Organization on Friday warned that the COVID-19 pandemic is not yet over and said there's a possibility of new variants. WHO Director-General Tedros Adhanom Ghebreyesus told attendees at the Munich Security Conference in Germa..